Peninsula biotech coughs up 40 percent of its value on failed clinical trial By: San Francisco Business Times via Business Journals October 08, 2018 at 17:43 PM EDT The company raised $137 million in a January IPO, but its stock now is 64 percent lower than the IPO. Read More >>
